Gait variability in Parkinson's disease: influence of walking speed and dopaminergic treatment.

@article{Bryant2011GaitVI,
  title={Gait variability in Parkinson's disease: influence of walking speed and dopaminergic treatment.},
  author={Mon S. Bryant and Diana H. Rintala and Jyhgong Gabriel Hou and Ann L Charness and {\'A}ngel L. Fern{\'a}ndez and Robert L. Collins and Jeff Baker and Eugene C. Lai and Elizabeth J. Protas},
  journal={Neurological research},
  year={2011},
  volume={33 9},
  pages={
          959-64
        }
}
OBJECTIVES To study the effects of levodopa and walking speed on gait variability in individuals with Parkinson's disease (PD). METHODS Thirty-three individuals with PD were studied. Their mean age was 70.61±9.23 year. The average time since diagnosis was 9.65±5.80 year. Gait variability was studied while 'OFF' and 'ON' dopaminergic medication when the subjects walked at their usual and fastest speeds. RESULTS Variability of step time, double support time, stride length and stride velocity… CONTINUE READING

Topics from this paper.

Citations

Publications citing this paper.
SHOWING 1-10 OF 25 CITATIONS

Quantifying Motor Impairment in Movement Disorders

VIEW 4 EXCERPTS
CITES METHODS & BACKGROUND
HIGHLY INFLUENCED

Progression of gait dysfunction in incident Parkinson's disease: impact of medication and phenotype.

VIEW 6 EXCERPTS
CITES BACKGROUND & RESULTS
HIGHLY INFLUENCED

Assessment of Motor Impairments in Early Untreated Parkinson's Disease Patients: The Wearable Electronics Impact

VIEW 1 EXCERPT